Last Updated on August 20, 2024 by The Health Master
WHO TRS
WHO TRS Guidelines: The Central Drugs Standard Control Organisation (CDSCO) has issued a letter to all vaccine and sterile product manufacturers in India.
The regulatory body has mandated strict adherence to the World Health Organization’s (WHO) Technical Report Series (TRS) guidelines 1044 Annexure 2 (WHO TRS 1044 Annexure 2) on sterile products.
This move is a direct consequence of the revised Schedule M, a set of stringent regulations governing the pharmaceutical industry.
What Does This Mean for Vaccine and Sterile Product Manufacturers?
The CDSCO’s directive is clear: manufacturers must align their operations with the latest WHO TRS guidelines.
This includes a comprehensive overhaul of production processes, quality control measures, and sanitation standards.
The revised Schedule M outlines specific requirements such as:
- Clean room standards: Maintaining immaculate production environments to minimize contamination.
- Airborne particle control: Implementing measures to reduce the presence of particles in the air.
- Microbial contamination limits: Enforcing strict standards to prevent product contamination.
- Robust quality control: Ensuring product safety and efficacy through rigorous testing.
The Impact on MSMEs
The pharmaceutical industry, particularly the Micro, Small, and Medium Enterprises (MSMEs) segment, is facing a significant challenge.
The implementation of the revised Schedule M requires substantial investments in infrastructure and technology.
Consequently, MSMEs have been urging the government to extend the compliance deadline.
A Step Towards Better Patient Safety
While the new regulations may impose a financial burden on manufacturers, especially MSMEs, they are ultimately aimed at safeguarding public health.
By adhering to the WHO TRS guidelines, pharmaceutical companies can ensure the production of high-quality, safe, and effective medicines.
This move is expected to enhance patient confidence in the Indian pharmaceutical industry.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
India allows Clinical Trial waivers for Drugs from these 6 Countries
USFDA approval granted for Acitretin Capsules USP
New Rules accelerate Drug Approval Process in India
Gujarat FDCA Launches Crackdown on Fake Drugs: Special Flying Squads Formed
Govt Job: For Pharmacists in Indian Railways – 246 posts
USFDA warns of Quality Issues with Chinese Plastic Syringe
Data integrity is the biggest issue in Pharma Industry: USFDA official
USFDA issues OAI Classification to Aurobindo Pharma Bhiwadi Facility
Indian Pharma industry urges NPPA for stable drug pricing policy
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
